loadpatents
Patent applications and USPTO patent grants for Paparin; Jean-Laurent.The latest application filed is for "non-fused thiophene derivatives and their uses".
Patent | Date |
---|---|
Antiviral benzyl-amine phosphodiamide compounds Grant 11,123,355 - de Lera Ruiz , et al. September 21, 2 | 2021-09-21 |
Non-fused Thiophene Derivatives And Their Uses App 20210040059 - MELDRUM; ERIC ;   et al. | 2021-02-11 |
Fused Thiophene Derivatives And Their Uses App 20200369682 - MELDRUM; ERIC ;   et al. | 2020-11-26 |
Nucleotides for the treatment of cancer Grant 10,815,264 - Dousson , et al. October 27, 2 | 2020-10-27 |
Antiviral phosphodiamide prodrugs of tenofovir Grant 10,745,428 - Raheem , et al. A | 2020-08-18 |
Antiviral aryl-amide phosphodiamide compounds Grant 10,736,908 - Paparin , et al. A | 2020-08-11 |
Antiviral aliphatic ester prodrugs of tenofovir Grant 10,519,159 - Paparin , et al. Dec | 2019-12-31 |
Antiviral Benzyl-amine Phosphodiamide Compounds App 20190321380 - de Lera Ruiz; Manuel ;   et al. | 2019-10-24 |
Antiviral prodrugs of tenofovir Grant 10,449,208 - Da Costa , et al. Oc | 2019-10-22 |
Antiviral Aryl-amide Phosphodiamide Compounds App 20190262365 - Paparin; Jean-Laurent ;   et al. | 2019-08-29 |
Antiviral Prodrugs Of Tenofovir App 20190183912 - Da Costa; Daniel ;   et al. | 2019-06-20 |
3'-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV Grant 10,202,411 - Dukhan , et al. Feb | 2019-02-12 |
Antiviral Phosphodiamide Prodrugs Of Tenofovir App 20180362562 - Raheem; Izzat Tiedje ;   et al. | 2018-12-20 |
Nucleotides For The Treatment Of Cancer App 20180208621 - Dousson; Cyril B. ;   et al. | 2018-07-26 |
Antiviral Aliphatic Ester Prodrugs Of Tenofovir App 20180179208 - Paparin; Jean-Laurent ;   et al. | 2018-06-28 |
2'-dichloro And 2'-fluoro-2'-chloro Nucleoside Analogues For Hcv Infection App 20170198005 - Paparin; Jean-Laurent ;   et al. | 2017-07-13 |
Nucleoside Derivatives For The Treatment Of Cancer App 20170101431 - Dousson; Cyril ;   et al. | 2017-04-13 |
3'-substituted Methyl Or Alkynyl Nucleosides Nucleotides For The Treatment Of Hcv App 20170044205 - DUKHAN; David ;   et al. | 2017-02-16 |
Hepatitis C Virus Inhibitors App 20160229866 - Dousson; Cyril B. ;   et al. | 2016-08-11 |
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors Grant 9,187,496 - Dousson , et al. November 17, 2 | 2015-11-17 |
5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitors App 20130071352 - Dousson; Cyril B. ;   et al. | 2013-03-21 |
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors Grant 8,362,068 - Dousson , et al. January 29, 2 | 2013-01-29 |
Methods For Treating Drug-resistant Hepatitis C Virus Infection With A 5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitor App 20120252721 - Dousson; Cyril B. ;   et al. | 2012-10-04 |
Phosphothiophene and phosphothiazole HCV polymerase inhibitors Grant 8,193,372 - Dousson , et al. June 5, 2 | 2012-06-05 |
Composition Comprising Ocaperidone App 20120009266 - KHANNA; Satish ;   et al. | 2012-01-12 |
5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitors App 20110150827 - Dousson; Cyril B. ;   et al. | 2011-06-23 |
Phosphadiazine HCV polymerase inhibitors IV Grant 7,932,240 - Dousson , et al. April 26, 2 | 2011-04-26 |
Phosphothiophene And Phosphothiazole Hcv Polymerase Inhibitors App 20100233123 - Dousson; Cyril ;   et al. | 2010-09-16 |
Phosphadiazine Hcv Polymerase Inhibitors Iv App 20090081158 - Dousson; Cyril ;   et al. | 2009-03-26 |
Phosphadiazine Hcv Polymerase Inhibitors V App 20090060872 - Dousson; Cyril ;   et al. | 2009-03-05 |
Ocaperidone Salts and Pharmaceutical Compositions Containing the Same App 20080200479 - Biondi; Stefano ;   et al. | 2008-08-21 |
Composition Comprising Ocaperidone App 20080103159 - Khanna; Satish ;   et al. | 2008-05-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.